Extension Letter Amendment to Consulting Agreement between AVEO Pharmaceuticals, Inc. and Lynda Chin, MD (March 30, 2011)

Summary

AVEO Pharmaceuticals, Inc. and Dr. Lynda Chin have agreed to extend the term of their existing Consulting Agreement. The amendment, effective January 1, 2011, extends the consultation period through December 31, 2011, unless the agreement is terminated earlier as specified in the original contract. All other terms and obligations of the original Consulting Agreement remain unchanged.

EX-10.2 3 dex102.htm EXTENSION LETTER AMENDMENT, DATED MARCH 30, 2011 - LYNDA CHIN Extension Letter Amendment, dated March 30, 2011 - Lynda Chin

Exhibit 10.2

75 Sidney Street, 4^th Floor

Cambridge, MA 02139

Phone: 617 ###-###-####

Fax: 617 ###-###-####

March 30, 2011

Lynda Chin, MD

89 Hyslop Road

Brookline, MA 02445

Re:	Consulting Agreement by and between Lynda Chin, MD and AVEO Pharmaceuticals, Inc effective as of January 1, 2010 (the “Consulting Agreement”)

Dear Dr. Chin,

It is hereby agreed that Section 2 of the Consulting Agreement shall be amended, effective as of January 1, 2011, to extend the Consultation Period through and including December 31, 2011 unless sooner terminated in accordance with Section 11 of the Consultant Agreement. All other terms and obligations under the Consulting Agreement shall remain the same.

Sincerely,

/s/ Murray O. Robinson

Murray O. Robinson, PhD

Senior Vice President, Translational Research

Co-chair of the Scientific Advisory Board

Agreed and Acknowledged:

/s/ Lynda Chin

Lynda Chin, MD